about
Survivin: A molecular biomarker in cancerTargeting survivin in cancerPrognostic role of survivin in bladder cancer: a systematic review and meta-analysisStructural Basis for Recognition of H3T3ph and Smac/DIABLO N-terminal Peptides by Human SurvivinSurvivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injuryYM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells.Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cellsApplication of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancersSurvivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancerSilencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancerPAK1 as a therapeutic target.Early diagnostic value of survivin and its alternative splice variants in breast cancer.Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysisRNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivoMultifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian CancerTheranostic properties of a survivin-directed molecular beacon in human melanoma cells.Report of the EORTC-PAMM Meeting, Brussels, 16-18 March 2009: new strategies for a targeted and personalised therapy of cancer.The role of survivin in diagnosis, prognosis and treatment of breast cancer.Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft ModelsExpression of p16 and Survivin in gliomas and their correlation with cell proliferationDifferential regulation of intracellular factors mediating cell cycle, DNA repair and inflammation following exposure to silver nanoparticles in human cellsPrognostic relevance of survivin in pancreatic endocrine tumorsThe antagonistic effect between STAT1 and Survivin and its clinical significance in gastric cancerLocal injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrestSurvivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancerMarkedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia.Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population.Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissuesMechanisms and therapeutic implications of cell death induction by indole compounds.HtrA serine proteases as potential therapeutic targets in cancer.Molecular changes in pancreatic cancer.Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.Development of target-specific treatments in multiple myeloma.Targeting survivin in cancer: patent review.Targeting inhibitor of apoptosis proteins for therapeutic intervention.Synthesis and characterization of Fe3O4-PEG-LAC-chitosan-PEI nanoparticle as a survivin siRNA delivery system.Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression.miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.Korean Red Ginseng Extract Enhances the Anticancer Effects of Imatinib Mesylate Through Abrogation p38 and STAT5 Activation in KBM-5 Cells.
P2860
Q26823439-4D73432D-306B-47B9-A796-6202A4E53D2AQ27012954-7ABE1F78-9FD0-4CA1-8018-9471FD8E2544Q27028122-BDB447DD-1127-4490-A234-F317A8F42424Q27676734-FF7B1772-EBD1-4A76-83C9-AF4DAA2134DCQ28574450-3F7FE032-0120-47AE-B9ED-B7968CBB4843Q33626354-797A52A6-BFAF-45CA-86CD-1587FA04AA4DQ34234351-C9C10A06-D407-473B-B3A8-0FDA0A5DADFEQ34556898-E70D5F25-CAA5-4385-868C-5D7EFE0BC79FQ34992551-BA7C0EA2-6BB1-45C1-9B64-08619DABD6E6Q34994521-142820E8-D0FF-484D-8F26-B78827481216Q35024933-2ED3868C-10F8-4A31-9CE1-7A4D7625E171Q35108164-EF766438-97A9-4825-9FCE-01A7B46A3437Q35118374-01204D15-A8C9-45EF-90FD-A5066B04C3AEQ35119245-B7AB679A-FA1D-40DC-83B4-A41B5ACF7B3FQ35225270-3BB10AC6-96B3-4A02-A236-623DE7A6E386Q35374920-82A72626-F133-400B-A38D-EAFC0F367016Q35515042-F469D053-ED3B-4D64-B7F9-C503383BD761Q35572921-4724E61B-16A2-41E6-8ED9-CE9CC37144CDQ35667653-DBE6755E-F239-46AF-BEE5-EBD99D51A14AQ35694238-2B61B085-A485-484C-9FB5-9F65D3AF450CQ35803811-587A55C9-A528-4DDA-96A3-EC5BB49C92BBQ35834390-F3BE1B72-D847-4F1F-8EED-1BC66310625EQ35947272-F113F562-A69C-4A48-836F-5731FD673664Q35995977-179AB7CE-3A9F-4301-A0A9-01B6E063F9DEQ36305414-C28E036B-8AEF-44B2-A299-84AC73B1B118Q36367559-AC4F5450-78E3-4996-B4DC-C7FA3BC5E678Q36682843-CD33372D-4AFF-4F89-A7FC-2252C8BA5C9AQ36836496-3DB07E9C-2E5D-48CC-81CF-C895A7FA8361Q36916428-6BBC9C0A-16AF-4681-9B12-7680A59205DFQ37137367-D880901A-41CA-476E-80D7-36148E345DA0Q37515512-DB6DA1B0-F910-46CE-A889-EA9CBF2001C1Q37614592-4635FA58-C0E1-4CBC-806B-73FBC9123C2DQ37746154-FE64BB27-6C54-4BD0-BD55-467718B5881DQ37771370-1F3EED1F-B410-4092-B3DF-66913CDEC114Q37810294-09116226-270C-43C4-B1F3-340B25E10819Q37855868-E99975FF-D601-45E3-A342-33D527F4581FQ38772046-D916DB51-3783-4D59-AC2B-93D10A2AC0B6Q38779461-0BE79684-3690-40FE-97ED-3EE3C4501F8AQ38883702-976C754B-9362-4FDD-BAC5-4DEFEB85A380Q38889273-5936CA78-DFED-47DE-90FD-E916CD9E52F1
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Targeting survivin in cancer therapy
@ast
Targeting survivin in cancer therapy
@en
Targeting survivin in cancer therapy
@nl
type
label
Targeting survivin in cancer therapy
@ast
Targeting survivin in cancer therapy
@en
Targeting survivin in cancer therapy
@nl
prefLabel
Targeting survivin in cancer therapy
@ast
Targeting survivin in cancer therapy
@en
Targeting survivin in cancer therapy
@nl
P2860
P1476
Targeting survivin in cancer therapy
@en
P2093
Marzia Pennati
P2860
P304
P356
10.1517/14728222.12.4.463
P407
P577
2008-04-01T00:00:00Z